The updated Plastic and Reconstructive Surgery Information for Authors has moved.
Please visit this site for the updated version: Plastic and Reconstructive Surgery Information for Authors.
Author Resources | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Instructions
for Authors
The goal of Plastic and Reconstructive Surgery� is to inform readers about significant developments in all areas related to reconstructive and cosmetic surgery. Significant papers on any aspect of plastic surgery�original clinical or laboratory research, operative procedures, comprehensive reviews, cosmetic surgery�as well as selected ideas and innovations, letters, viewpoints, and video plus articles are invited for publication. SUBMISSION OF MANUSCRIPTS All new manuscripts for
consideration need to be submitted online through PRS� Editorial Manager at:
http://www.editorialmanager.com/prs/.
Authors must have an e-mail address at which
they may be reached. We recommend adding [email protected]
to your contacts to avoid missing any correspondence.
Contact Us: EDITORIAL
POLICIES Ethical Approval of Studies/Informed Consent Authors of manuscripts that describe experimental studies on either humans or animals must supply to the Editor a statement that the study was approved by an institutional review committee or ethics committee and that the subjects gave informed consent. Such approval should be described in the Methods section of the manuscript. In addition, for studies conducted with human subjects, the method by which informed consent was obtained from the participants (i.e., verbal or written) also needs to be stated in the Methods section. In those situations where a formal institutional review board process is not available, the authors must indicate that the principles outlined in the Declaration of Helsinki have been followed. More information regarding the Declaration of Helsinki can be found at http://www.wma.net/en/30publications/10policies/b3/ (Web site last accessed on December 9, 2014). Registering Clinical Trials Plastic and Reconstructive Surgery strongly encourages all articles reporting results of clinical trials to be registered in a public trials registry that is in conformity with the International Committee of Medical Journal Editors (ICMJE). All clinical trials, regardless of when they were completed, and secondary analyses of original clinical trials should be registered before submission of a manuscript based on the trial. Phase I trials designed to study pharmacokinetics or major toxicity are exempt. Registering your trial is easy, free of charge, and helps promote science among a wide range of researchers. Manuscripts reporting on clinical trials (as defined above) should indicate that the trials are registered and include the registry information on a separate page, immediately following the authors’ financial disclosure information. Required registry information includes trial registry name, registration identification number, and the URL for the registry. Trials should be registered in one of the following trial registries:
More information on registering clinical trials can be found in the following article: Rohrich RJ, Longaker MT. Registering clinical trials in Plastic and Reconstructive Surgery. Plast Reconstr Surg. 2007;119(3):1097-1099. Manuscripts containing original material are accepted for consideration if neither the article nor any part of its essential substance, tables, or figures has been or will be published or submitted elsewhere before appearing in the Journal (in part or in full, in other words or in the same words, in English or in another language), and will not be submitted elsewhere unless rejected by the Journal or withdrawn by the author. If an author violates this requirement or engages in similar misconduct, the Journal’s Editorial Board may reject the manuscript or impose a moratorium on acceptance of new manuscripts from the author. If it deems the misconduct sufficiently serious, the Editorial Board can refer the matter for investigation to the author’s academic institution or hospital, to the appropriate state or local disciplinary body, and/or to the Ethics Committee of the American Society of Plastic Surgeons. Compliance with NIH and Other Research Funding Agency Accessibility Requirements A number of research funding agencies now require or request authors to submit the post-print (the article after peer review and acceptance but not the final published article) to a repository that is accessible online by all without charge. As a service to our authors, LWW will identify to the National Library of Medicine (NLM) articles that require deposit and will transmit the post-print of an article based on research funded in whole or in part by the National Institutes of Health, Wellcome Trust, Howard Hughes Medical Institute, or other funding agencies to PubMed Central. The revised Copyright Transfer Agreement provides the mechanism. All published material becomes the sole property of the Journal, copyrighted by the American Society of Plastic Surgeons. By submitting an article, letter to the Editor, or brief communication, all authors agree to each of these conditions. By signing the PRS eCTA (electronic Copyright Transfer Agreement), aka electronic author forms, you are transferring copyright of figures, tables, videos, and the content of the manuscript to the American Society of Plastic Surgeons. If you do not wish to - or cannot - transfer copyright of some or all of your content, please indicate this in the eCTA and contact the Editorial Office at [email protected]. Proper copyright language, indications, and permissions documentation will have to be provided for each item on which copyright is retained by the authors or by a third party (independent illustrator, original publisher, etc). Successfully revising a manuscript does not guarantee acceptance. The Editor-in-Chief maintains the right to submit accepted manuscripts to further reviews, revisions, and possible change of status based on potential LEGAL, ETHICAL, and BIOSTATISTICAL ISSUES which become evident prior to publication. This may result in the article being further revised or even withdrawn from publication entirely at any point during the publication process. Research Guidelines and Summary Rejection In addition, the following guidelines will be enforced to ensure the publication of high-quality research:
Much of this policy is adapted from the article “Common Fallacies in Designing a Research Project: Guidance Principles” (Plast Reconstr Surg. 2019;144:1247–1253). Please review this article to learn more about the Journal’s research guidelines and recommendations. Cascading Peer Review PRS utilizes a ‘cascading peer review method’ whereby manuscripts not acceptable for PRS, but deemed suitable for the American Society of Plastic Surgeon’s Open Access journal PRS Global Open will automatically be considered for publication in PRS Global Open. Authors of such manuscripts will receive an email indicating the decision to not accept the article in PRS and an offer to automatically transfer the manuscript to the PRS Global Open editorial system. Authors will be able to click a link to ‘accept’ or ‘decline’ this offer; If ‘accept’ is clicked, the article will be automatically transferred and resubmitted to PRS Global Open’s Editorial Manager (www.editorialmanager.com/gox). Direct submissions to PRS Global Open are welcomed on that Journal’s Editorial Manager homepage: www.editorialmanager.com/gox Additional Peer Review Policies The peer review process is handled entirely electronically via PRS's Editorial Manager. Peer reviewers are instructed to review the contents of the submission in a critical, unbiased, and timely fashion. They review all pieces of the submission, including the manuscript itself as well as videos, tables, and images. The Editor-in-Chief is excluded from managing the peer review process for any manuscript that includes the Editor-in-Chief as an author or otherwise comes from his institution. The Co-Editor performs the necessary duties in these instances. Authors may suggest reviewers for their manuscripts, but there is no guarantee that the Editor-in-Chief will select any to serve on the review panel. PRS currently utilizes the single-blind method of peer reviewing. Read more: PRS Editorial, Legal, and Ethical Policies. E-articles The Editor-in-Chief has the discretion to select some articles to publish online as e-articles. The e-article designation is not an indicator of quality or preference.� Each month, all Letters, Replies, Viewpoints, and the CME article, as well as randomly selected articles in the issue, are published as e-pages. The CME and any non-Letter or -Viewpoint article have corresponding �teaser� pages in print. E-articles are assigned at random based on the table of contents order; any accepted or published article may be considered for e-article publication in an issue of PRS without author notification. Written and Video Discussions Expert written or video discussions are solicited at the discretion of the Editor-in-Chief based on criteria including but not limited to the parent article�s status as a hot topic, a study of unique interest to the field or the public, or a controversial subject area. PRS protocols do not include notifying authors that a discussion has been solicited or accepted on their manuscript. The Editor-in-Chief has the discretion to request such discussions or counterpoints from editorial board members, members of the peer review panel, or other subject experts. Discussion authors that served on the peer review panel are only allowed to base their discussion on the accepted manuscript; they are barred from commenting on any previous iterations of the study as presented through the iterative editorial process. We do not allow letters to the editor regarding solicited discussions or allow for counter-counter point on discussions, except in infrequent instances at the Editor-in-Chief�s discretion. PRS does request reply letters based on unsolicited letters to the editors regarding published manuscripts. Preprint Policy Manuscripts submitted to PRS Journals should not have been published previously in print or electronic format. Public dissemination or posting of manuscripts prior to, simultaneous with, or after submission to this Journal, such as posting the paper on preprint servers or other repositories, will require the Editor to make a determination of whether publishing this submitted manuscript will add sufficient new information to the medical literature or will be duplicative with information already published on the preprint server or similar medium. Given the Journals� duplicate submission policy, if the preprint is found to be largely similar to the PRS Journals submission, the editors will decline the opportunity to consider the submission without prejudice. At the time of submission, authors should notify the Editor of any prior postings or publications (print or electronic) of this article. Authors must provide related active links to or copies of any preprint postings. Duplicate Submissions/Publications Manuscripts containing original material are accepted for consideration if neither the article nor any part of its essential substance, tables, or figures has been or will be published or submitted elsewhere before appearing in the Journal (in part or in full, in other words or in the same words, in English or in another language), and will not be submitted elsewhere unless rejected by the Journal or withdrawn by the author. Simultaneous submissions of the same article to multiple journals are prohibited. Although there are occasional legitimate purposes for multiple manuscripts drawn from the same study, by and large this practice- also known as �Salami Slicing�- is a publishing ethics violation and is prohibited. If you feel that the broken-up pieces of a single study have different hypotheses, populations, methods, etc, then you MUST cite all additional studies and discuss this openly in the cover letter and in the body of the manuscript itself. In general, we urge all authors to avoid inappropriately breaking up data from a single study into two or more papers. Be transparent when submitting. Send copies of any closely related manuscripts to the Editor-in-Chief. This includes any manuscripts that are being considered by another journal, published by another journal, or published by a preprint server or other entity. If an author violates these requirements or engages in similar misconduct, the Journal's Editorial Board may reject the manuscript or impose a moratorium on acceptance of new manuscripts from the author. If it deems the misconduct sufficiently serious, the Editorial Board can refer the matter for investigation to the author's academic institution or hospital, to the appropriate state or local disciplinary body, and/or to the Ethics Committee of the American Society of Plastic Surgeons. Multi-Part Papers PRS does not consider multi-part papers for publication (i.e., Part 1, Part 2). Because all manuscripts are reviewed individually, there is no guarantee that all parts would be accepted or published together. To ensure that all studies are reviewed and (if accepted) published in their entirety, the Editor may request that multi-part papers be combined into one manuscript. NECESSARY FILES FOR ELECTRONIC SUBMISSION ON PRS’ Editorial Manager
Note: The above items should be prepared as separate files. Each file MUST contain a file extension (.doc, .tif, .eps, etc.).
ONLINE MANUSCRIPT SUBMISSION First-Time Users: Please click the Register button and enter the requested information. Upon successful registration, you will be sent an e-mail indicating your user name and password. Print a copy of this information for future reference. NOTE: If you have received an e-mail from us with an assigned user ID and password, or if you are a repeat user, do not register again. Just log in. Once you have an assigned ID and password, you do not need to re-register, even if we add a new role to your account (such as reviewer, editorial board). MANUSCRIPT PREPARATION Authors are required to submit their manuscripts online through PRS’ Editorial Manager at: http://www.editorialmanager.com/prs/. Manuscripts not sent via the Editorial Manager system will not be processed. We are unable to accept the submission through email. All submission materials must be uploaded by the authors to ensure proper display and delivery. NOTE: Manuscripts that do not conform to the following regulations may be returned to the author for correction before being sent for peer review and at any point in the editorial process. General All copy must be double-spaced, including text, footnotes, references, figure legends, and tables. Each manuscript page must be numbered clearly, with the numbering continuing throughout. All references, figures, and tables must be numbered and must be cited in numerical order in the text. Citations of figures and tables show the printer where to place them in the text. If a statistical analysis is done, explanation of the method used must be stated in the text preceding the results. Unusual or complex methods of analysis should be referenced. Most papers that include statistical analyses are evaluated by a biostatistician during the review process. Manuscript Length/Number of Figures To enhance quality, readability and to be more competitive with other leading scientific journals, all manuscripts must now conform to the new word-count standards for article length and limited number of figure pieces:
*NOTE: BEGINNING JANUARY 1, 2022, PRS WILL NO LONGER ACCEPT OBITUARY SUBMISSIONS.
PLEASE NOTE: Figure pieces are individual images within a figure – so a figure with a pre-op picture and a post-op photo contains TWO figure pieces that count against your total limit. *NOTICE Regarding Supplemental Digital Content (including Videos): Beginning March 1, 2022, submissions to PRS must adhere to the following limits for Supplemental Digital Content/Videos:
*Notes regarding video:
*Notes regarding tables: Tables cannot include photographs. Tables that do include photographs will be processed as figures. In some instances, tables can include small graphics including shapes or simple line drawings. These are considered on a case-by-case basis. Articles not meeting the above standards will be returned to the author until the article meets the policies for their selected article type. Permissions/Consents A letter of permission is required for any and all material that has been published previously, or for which the authors do not own the copyright. It is the responsibility of the author to request permission from the publisher (or owner of the copyrighted item) for any material that is being reproduced. This requirement applies to text, illustrations, photos, and tables. Authors are also required to obtain written releases from any person whose photographs are submitted to the Journal for publication if the person can be identified. A standardized patient authorization form for the release of patient photographs as well as a general consent form (for doctors, nurses, etc.) may be printed from our site. If an author chooses to use his or her own version for patient authorization, the form must include permission to use photographs for all types of media including but not limited to the following: print, visual, electronic, or broadcast media. Also, details in text that might identify patients should be avoided unless essential for scientific purposes. If identification of patients is unavoidable, informed consents should be obtained. Please note all consent forms should be in English.
Authorship Any clinical manuscripts (the subjects of which are humans, not experimental papers, or manuscripts that have clinical implications or applications) must have as their first and corresponding author a practicing physician(s). Coauthors from industry can certainly be included on a paper, but the corresponding author who takes ultimate senior responsibility on the paper must be a practicing clinical physician. Definition of ‘author’/Excessive Authorship: According to the International Committee on Medical Journal Editors (ICMJE), an author is defined as one who has made substantive intellectual contribution to the development of a manuscript. The ICMJE guidelines state that “authorship credit should be based on 1) substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; 2) drafting the article or revising it critically for important intellectual content; 3) final approval of the version to be published; 4) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Authors should meet conditions 1, 2, 3, and 4.” Authors of PRS articles must meet all four criteria of authorship. If more than 10 authors are listed for any given manuscript, it will be sent back to the Corresponding Author. Overage should be relocated to the “Acknowledgment” section of the manuscript. Special exceptions to this rule can be sought via special request to the Editor-in-Chief via the Editorial Office. If you wish to request to have between 11 and 20 authors, please contact the Editorial Office ([email protected]). The Editor-in-Chief will consider your request after you have filled out a form in which all authors attest and sign that they have fulfilled all 4 conditions of authorship. Manuscripts with more than 20 authors will not be considered for publication at this time. DECLARATION OF AUTHORSHIP FORM Post-submission Changes in Authorship: After the initial submission of a manuscript, any changes whatsoever in authorship (adding author(s), deleting author(s), or re-arranging the order of authors) must be explained by a letter to the Editor from the authors concerned. This letter must be signed by all authors on the paper, including any that may have been removed. Copyright assignment must be completed by every author. This can be done via the ‘author forms.’ Title Page The title page includes the complete title of the article; a separate list of authors’ names spelled out with middle initials and highest academic degrees (please list in the following order: first name, middle initial, last or family name. i.e. John R. Smith); a list indicating each author’s affiliations and city; a footnote listing meetings at which the paper has been presented; and a short running head (no more than 40 characters in length). Please use this template to created your title page for your manuscript. If your manuscript is selected to run ahead of print as a “PRS Online First” manuscript, it will be advanced online to accelerate publication and, therefore, will not have undergone copyediting or proofing yet. Author names will be published exactly as they appear in the title page; if the template is not followed and the article is selected for PRS Online First Publication, we cannot guarantee proper presentation of the last name. If there is any confusion as to first name and last/family name, please make it abundantly clear in the author list as to the family name by bolding it or other means. PRS Online First publications are replaced on our website and on PubMed when the final, proofed version is published; so authors do have an opportunity at proof stage to correct any errors. Academic Degrees for Authors Please limit the total number of academic degrees to a maximum of three (3). Corresponding Author Contact Information Page The second page should contain the complete name and address of the corresponding author, or the author who is responsible for handling reprints. This information must include an e-mail address. Financial Disclosure and Products Page On the third page of the manuscript, all sources of funds supporting the work and a statement of financial interest, if any, must be included for each author, along with a list of all products, devices, drugs, etc., used in the manuscript. All manuscripts must have all of this information. Each author must disclose at the time of submission any commercial associations or financial disclosures that might pose or create a conflict of interest with information presented in any submitted manuscript. Such associations include consultancies, stock ownership, or other equity interests, patent licensing arrangements, and payments for conducting or publicizing a study described in the manuscript. Authors must disclose any funding received for this work from any of the following organizations: National Institutes of Health (NIH); Wellcome Trust; Howard Hughes Medical Institute (HHMI); and other(s). This information will be printed with the article. Structured Abstract Page Original articles and Experimental studies must begin with a structured abstract. The abstract should include the headings: Background, Methods, Results, and Conclusions. We encourage potential authors to look at recent issues of the Journal for examples of similar articles. Special Topics and Ideas and Innovations articles should begin with a summary. The length for abstracts and summaries should be no more than 250 words. Levels of Evidence All manuscripts amenable to Level of Evidence grading will be assessed and have a clinical question and LOE grade assigned by a special, independent panel at the American Society of Plastic Surgeons headquarters. We no longer request that you provide an initial indication of clinical question or level of evidence. The final Level of Evidence grade for accepted papers will be determined and assigned by the independent panel of Level of Evidence experts. The following types of articles are not gradable for level of evidence:
As far as what is or is not ratable, the standard is to exclude basic science, bench work, and animal studies because the information gained from these studies is not something that can be applied directly to patient treatment decisions. See the article "The Level of Evidence Pyramid: Indicating Levels of Evidence in PRS Articles" in the July 2011 issue of Plastic and Reconstructive Surgery for more information. The clinical question will be one of three categories: Diagnostic, Therapeutic, or Risk. American Society of Plastic Surgeons Rating Levels of Evidence and Grading Recommendations Evidence Rating Scale for Therapeutic Studies
Evidence Rating Scale for Diagnostic Studies
Evidence Rating Scale for Prognostic/Risk Studies
Text The body of the text must conform to acceptable English usage and syntax; the contents must be clear, accurate, coherent, and logical. Avoid using abbreviations unless they are so common that they are never spelled out. The Journal aims for optimal readability. Following the references, figure legends and tables, with complete credit lines for material that has been published previously, must be listed on separate pages. All figure legends and tables must be double-spaced. Figures and tables must be cited in numerical order in the text. Invited Discussions of accepted manuscripts are frequently requested by the Editors. The preparation of Discussions is the same as for all other articles. The title page for a Discussion should include the title of the original article and the words “Discussion by” followed by the author or authors of the Discussion. All Letters to the Editor must be double-spaced. The title of your letter should be identical to the title of the published article being discussed. If it is not, the Publisher reserves the right to alter the title accordingly. The title must appear at the beginning of the correspondence; a complete reference must be given for any article that is being discussed, and should be the first reference listed; all authors must be listed at the end, followed by the complete address of the corresponding author; and references must be prepared in the appropriate style. The Journal will only consider Letters to the Editor if they are received within 2 full months after an article's publication date. SUPPLEMENTAL DIGITAL CONTENT (VIDEOS, ETC) Online-only Materials:
Please note: any video submission over 30 seconds in length must contain English-language subtitles or narration. All online-only materials will be subject to peer review and published at the Editor-in-Chief’s discretion. The Supplemental Digital Content feature of PRS will not be used merely as a receptacle and vehicle for superfluous materials. Please choose these materials judiciously and make sure they are demonstrative and necessary rather than excessive and redundant. Supplemental Digital Content Limitations: Your SDC may include a combination of the following material, for a maximum of 8 total SDC files:
AND *NOTICE Regarding Supplemental Digital Content (including Videos): Beginning March 1, 2022, submissions to PRS must adhere to the following limits for Supplemental Digital Content:
SDC Materials Citation Guidelines:
SDC Size & File Type Requirements:
For more information, please review LWW’s requirements for submitting supplementary materials: http://edmgr.ovid.com/lww-final/accounts/SuppMaterialRequirements.doc Stand-Alone Videos Please limit Stand-Alone submissions to superb independent content. If the long-format video seems to supplement written article content more so than stand alone as an independent contribution, please break the video into shorter Supplemental Digital Content Videos. If the video truly stands on its own, this is ideal for a Stand-Alone Video. All Stand-Alone materials will be subject to peer review and published at the Editor-in-Chief’s discretion. The Editor-in-Chief retains the right to request that a Stand-Alone submission be broken into shorter clips and reconsidered as Supplemental Digital Content downloadable videos. The following content types MUST comply with the dimension and file size requirement for Stand-Alone Video:
FIGURES Articles will contain no more than 20 figure pieces due to page constraints. Please note that each panel of a multi-panel figure is counted as one “figure piece.” For definition purposes, one figure containing a pre-op and a post-op counts as two figure pieces. There is no charge to authors for color printing.
Any figures submitted that do not meet the above standards will be sent back to the authors and new images will be requested. If better quality images are not supplied, figures may be removed from the manuscript, or moved to Supplemental Digital Content.
COPYRIGHT INFORMATION: Please note that by signing the PRS eCTA (electronic Copyright Transfer Agreement), aka electronic author forms, you are transferring copyright of figures, tables, videos, and the content of the manuscript to the American Society of Plastic Surgeons. If you do not wish to - or cannot - transfer copyright of some or all of your content, please indicate this in the eCTA and contact the Editorial Office at [email protected]. Proper copyright language, indications, and permissions documentation will have to be provided for each item on which copyright is retained by the authors or by a third party (independent illustrator, original publisher, etc).Creating Digital Artwork Please note that by signing the PRS eCTA (electronic Copyright Transfer Agreement), aka electronic author forms, you are transferring copyright of figures, tables, videos, and the content of the manuscript to the American Society of Plastic Surgeons. If you do not wish to - or cannot - transfer copyright of some or all of your content, please indicate this in the eCTA and contact the Editorial Office at [email protected]. Proper copyright language, indications, and permissions documentation will have to be provided for each item on which copyright is retained by the authors or by a third party (independent illustrator, original publisher, etc).Creating Digital Artwork
Digital Artwork Guideline Checklist
To avoid errors during publication:
NOTE: Additional instructions for the Journal’s policies on Supplements, Discussions, references, SDC, and videos are available at the Journal’s Web site, www.PRSJournal.com. Authors who are not native speakers of English who submit manuscripts to international journals often receive negative comments from referees or editors about the English–language usage in their manuscripts, and these problems can contribute to a decision to reject a paper. To help reduce the possibility of such problems, we encourage authors to consider seeking English-language revision assistance. There are many sources authors can turn to for such assistance, including partnering with a native English-speaking co-author and hiring third party author services firms. There are many firms authors can turn to; PRS does not recommend one firm over another, however we can confirm that Wolters Kluwer Author Services* is a trustworthy service provider. Wolters Kluwer Author Services
For more information regarding Wolters Kluwer Author Services, please visit http://wkauthorservices.editage.com. *Note that the use of such a service is at the author's own expense and risk, and does not guarantee that the article will be accepted. Manuscript Preparation Author Checklist Copy this form or download from http://www.PRSJournal.com and www.editorialmanager.com/prs Use this checklist to help you include all required elements of your submission.
Any manuscript that does not include the items listed in this checklist may be returned to the corresponding author for additional information. MANUSCRIPTS AFTER ACCEPTANCE Once an author receives notice of acceptance, the manuscript is then placed into our accepted queue by section. The Editor-in-Chief will then selected the manuscript for an upcoming publication based on the acceptance date, the authors will be notified via email to let them know which issue their article was placed in Manuscript Preparation Once selected for an issue the article is prepared for publication by the Editorial Office. Prompt response to Editorial Office requests for additional information or improved figures is necessary to ensure timely publication. Delays in providing necessary additional information may result in publication delays. Electronic Page Proofs and Corrections Corresponding authors will receive electronic page proofs to check the copyedited and typeset article before publication. Portable document format (PDF) files of the typeset pages and support documents (e.g., reprint order form) will be sent to the corresponding author via e-mail. Complete instructions will be provided with the e-mail for downloading and marking the electronic page proofs. The corresponding author must provide an email address. The proof/correction process is done electronically. It is the author's responsibility to ensure that there are no errors in the proofs. Authors who are not native English speakers are strongly encouraged to have their manuscript carefully edited by a native English-speaking colleague. Changes that have been made to conform to journal style will stand if they do not alter the authors' meaning. Only the most critical changes to the accuracy of the content will be made. Changes that are stylistic or are a reworking of previously accepted material will be disallowed. The publisher reserves the right to deny any changes that do not affect the accuracy of the content. Authors may be charged for alterations to the proofs beyond those required to correct errors or to answer queries. Electronic proofs must be checked carefully and corrections returned within 24 to 48 hours of receipt, as requested in the cover letter accompanying the page proofs. Addition of authors at proof stage is not allowed. Articles may be moved to another issue or encounter delays in publication as determined necessary by the publisher and Editorial Office. To the degree possible, corresponding authors will be contacted regarding any unforeseen delay in publication. Reprints Authors will receive an email notification with a link to the order form soon after their article publishes in the journal (https://shop.lww.com/author-reprint). Reprints are normally shipped 6 to 8 weeks after publication of the issue in which the item appears. Contact the Reprint Department, Lippincott Williams & Wilkins, 351 W. Camden Street, Baltimore, MD 21201; fax: 410-558-6234; email: [email protected] with any questions. OPEN ACCESS POLICIES PRS is a hybrid open access journal. We offer the option to publish original research articles (Original, Experimental, Special Topic) as open access. If an author chooses to exercise the open access option, whether by obligation to publicly funded bodies or by choice, his or her accepted article can be published in Plastic and Reconstructive Surgery and made freely, openly available to all readers indefinitely. After the first round of peer review has concluded, the author will be presented with the option to choose open access. Before publication, the article processing charge would be paid. Once published, the article would be fully and permanently open to all readers on our Web site, PRSJournal.com. Articles that are open access are identified by the “open” icon. It is worth noting the following: * The peer review and production processes for open access articles published in Plastic and Reconstructive Surgery are identical to those for traditionally published articles. * Authors of open access articles retain copyright to their content. * Open access articles can be published ahead of print. * Open access articles will be deposited into PubMed Central on the authors’ behalf by our publishers. * Commercial reprints can be purchased for open access articles. * Previously published articles can be made open access going forward if the author so desires. * Open access articles and all related figures and tables have limited restrictions on permissions. Under the Creative Commons License, readers can disseminate and reuse the article for noncommercial purposes. * Open access articles can be posted to personal Web site and/or institutional repositories. * Only original, experimental, or special topic articles can be made open access. To reiterate, the open access option will not be offered to authors until after the article has been peer reviewed. Authors will be given the option to publish their paper as open access when the article is sent back for revision. The extension of this option does not indicate that the article will be accepted following resubmission. “ARTICLE PROCESSING CHARGE” Authors who opt for open access publication in Plastic and Reconstructive Surgery will be asked to pay an article processing charge. Starting January 1, 2021, the charge to publish in Plastic and Reconstructive Surgery is $3520 if the article is published under the Creative Commons License Attribution-Noncommerical No Derivative (CC-BY-NC-ND) license; it is $4270 if it is published under the Attribution 3.0 (CC-BY) license, which is required by Research Councils UK. These article processing charges are excluding tax/VAT. Any required taxes/VAT will be applied during the payment process. The intent of the article processing charge is not to make any profit; these funds cover administrative costs of peer review, expert copyediting, layout, typesetting, and hosting of the article as a PDF and full text on PRSJournal.com. Compliance with NIH and Other Research Funding Agency Accessibility Requirements A number of research funding agencies now require or request authors to submit the post-print (the article after peer review and acceptance but not the final published article) to a repository that is accessible online by all without charge. As a service to our authors, LWW will identify to the National Library of Medicine (NLM) articles that require deposit and will transmit the post-print of an article based on research funded in whole or in part by the National Institutes of Health, Wellcome Trust, Howard Hughes Medical Institute, or other funding agencies to PubMed Central. The revised Copyright Transfer Agreement provides the mechanism. For more information, read “Plastic and Reconstructive Surgery: A Hybrid Open-Access Medical Journal” by Rohrich and Weinstein. Plastic & Reconstructive Surgery: July 2014 - Volume 134 - Issue 1 - p 165–167 ADDITIONAL SUPPLEMENT POLICIES
ADDITIONAL GUIDELINES FOR IDEAS & INNOVATIONS Ideas & Innovations submissions should capture the essence of your work in a short, simplified manner. Manuscripts should be framed in a way that summarizes your experience and directly highlights the pearls you wish to share with readers. Ideas & Innovations should not be perceived as an avenue for “miniature Original Articles.” Ideas & Innovations do not need to focus on a scientific hypothesis/analysis nor conform to the standard format of a scientific paper (i.e., traditional sections such as “materials and methods” are not necessary). ADDITIONAL GUIDELINES FOR LETTERS TO THE EDITOR Letters to the Editor that advance the scientific conversation or are otherwise meaningful, discussing material recently published in the Journal, are welcome. The Journal will only consider Letters to the Editor if they are received within 2 full months after an article's publication date. Notice: Beginning on October 1 2021, PRS will be solely accepting and publishing Letters-to-the-Editor that advance the scientific conversation or are otherwise deemed meaningful by the Editor-in-Chief and Co-Editor. In lieu of merely cordial or non-impactful Letters-to-the-Editor, we encourage readers to contact the authors directly utilizing the published correspondence information. Letters to the Editor may be published with a response from the authors of the article being discussed. Discussions beyond the initial letter and response will not be published. Letters submitted pertaining to published Discussions of articles will not be printed. Letters to the Editor are not usually peer reviewed, but the Journal may invite replies from the authors of the original publication. All Letters are published at the discretion of the Editor. Letters submitted should pose a specific question that clarifies a point that either was not made in the article or was unclear, and therefore a response from the corresponding author of the article is requested. Corrections and mistakes from a published article can be emailed to [email protected]. Authors will be listed in the order in which they appear in the submission. Letters should be submitted electronically via PRS’ Editorial Manager, at www.editorialmanager.com/prs/. We reserve the right to edit Letters to meet requirements of space and format. Any financial interests relevant to the content of the correspondence must be disclosed. Submission of a Letter constitutes permission for the American Society of Plastic Surgeons and its licensees and assignees to publish it in the Journal and in any other form or medium. The views, opinions, and conclusions expressed in the Letters to the Editor represent the personal opinions of the individual writers and not those of the publisher, the Editorial Board, or the sponsors of the Journal. Any stated views, opinions, and conclusions do not reflect the policy of any of the sponsoring organizations or of the institutions with which the writer is affiliated, and the publisher, the Editorial Board, and the sponsoring organizations assume no responsibility for the content of such correspondence. The Journal requests that individuals submit no more than five (5) letters to Plastic and Reconstructive Surgery in a calendar year. NOTICE: Beginning on January 1, 2022, the Journal will allow no more than three (3) letters to Plastic and Reconstructive Surgery per individual per calendar year. ADDITIONAL INSTRUCTIONS FOR DISCUSSIONS Contents of the Discussion The goal of the Discussion is to enrich an article by presenting information and perspective based on the experience of the Discussant, who may agree or disagree with an author’s hypothesis, methodology, discussion, or conclusions. The Discussion should be succinct—not more than 800 words—but detailed, with references and/or figures and tables if pertinent. Authors are limited to 10 tables and/or figures. The Discussion should not become another paper and it should be more than a diatribe or a series of compliments and platitudes. If you served as a peer reviewer on this manuscript, it is pivotal that you do not discuss any version of the manuscript other than the final, accepted version sent to you today. Information gathered, opinions formed, or details recalled from previous versions of the manuscript along the editorial process should NOT be used to inform the content of your discussion. Previous versions of the manuscript are privately shared with peer reviewers and are not intended for public dissemination. If you feel that your role as peer reviewer has disabled your ability to offer an unbiased discussion of this manuscript, please decline the invitation. Format of the Discussion The first page of the Discussion should include the complete title of the manuscript under review, the authors of that paper, as well as your name, degree(s), and address. Your name and address should also appear at the conclusion of the Discussion. The title of your Discussion should be identical to the title of the article being discussed. If it is not, the Publisher reserves the right to alter the title accordingly. All Discussions should follow the general format and instructions provided in the Instructions for Authors. All Discussions should be submitted to PRS via PRS’ Editorial Manager on-line submission system at: http://www.editorialmanager.com/prs/. We can allow only approximately 4 weeks for a Discussion to complete the manuscript. If you are unable to finish within that time, please contact the Editorial Office. CLINICAL FOLLOW-UP ARTICLES Authors of Clinical Follow-Up articles should follow the general format and instructions provided in the Instructions for Authors. Please bear in mind that your manuscript should be of approximately 500 to 1000 words in length to bring the readership up to date on your current experience with the procedure that you previously described. These articles are intended to be an update only, not an original article. POLICY ON SOCIETY HISTORY ARTICLES 1. All listed groups for which PRS is the official Journal and select unlisted partnering groups/meetings will be allowed to submit for peer review and ultimately publish One Society-specific History article every 10 years. The history articles should meet the criteria of a PRS Special Topic article and are subject to peer review. 2. Listed groups can continue to publish their society-specific Abstract Supplements as per existing protocols, with requisite publication costs in PRS or PRS Global Open. 3. Paid-for Society-Specific History Supplements will be considered on a case-by-case basis. ADDITIONAL INSTRUCTIONS FOR REFERENCES The style for references follows the AMA (American Medical Association) Citation Style. Many resources exist in word processing programs and online to help format to the AMA Manual of Style. A few basic examples follow: Journal Articles Chapter in a Book Entire Book Proceedings Presentation World Wide Web
|